• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRODERS分类器(使用放射组学分层进行良性侵袭性结节评估)的验证,这是一种基于高分辨率CT的新型放射组学分类器,用于评估不确定的肺结节。

Validation of the BRODERS classifier (Benign aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.

作者信息

Maldonado Fabien, Varghese Cyril, Rajagopalan Srinivasan, Duan Fenghai, Balar Aneri B, Lakhani Dhairya A, Antic Sanja L, Massion Pierre P, Johnson Tucker F, Karwoski Ronald A, Robb Richard A, Bartholmai Brian J, Peikert Tobias

机构信息

Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

These authors contributed equally to this work.

出版信息

Eur Respir J. 2021 Apr 1;57(4). doi: 10.1183/13993003.02485-2020. Print 2021 Apr.

DOI:10.1183/13993003.02485-2020
PMID:33303552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8375083/
Abstract

INTRODUCTION

Implementation of low-dose chest computed tomography (CT) lung cancer screening and the ever-increasing use of cross-sectional imaging are resulting in the identification of many screen- and incidentally detected indeterminate pulmonary nodules. While the management of nodules with low or high pre-test probability of malignancy is relatively straightforward, those with intermediate pre-test probability commonly require advanced imaging or biopsy. Noninvasive risk stratification tools are highly desirable.

METHODS

We previously developed the BRODERS classifier (Benign aggRessive nODule Evaluation using Radiomic Stratification), a conventional predictive radiomic model based on eight imaging features capturing nodule location, shape, size, texture and surface characteristics. Herein we report its external validation using a dataset of incidentally identified lung nodules (Vanderbilt University Lung Nodule Registry) in comparison to the Brock model. Area under the curve (AUC), as well as sensitivity, specificity, negative and positive predictive values were calculated.

RESULTS

For the entire Vanderbilt validation set (n=170, 54% malignant), the AUC was 0.87 (95% CI 0.81-0.92) for the Brock model and 0.90 (95% CI 0.85-0.94) for the BRODERS model. Using the optimal cut-off determined by Youden's index, the sensitivity was 92.3%, the specificity was 62.0%, the positive (PPV) and negative predictive values (NPV) were 73.7% and 87.5%, respectively. For nodules with intermediate pre-test probability of malignancy, Brock score of 5-65% (n=97), the sensitivity and specificity were 94% and 46%, respectively, the PPV was 78.4% and the NPV was 79.2%.

CONCLUSIONS

The BRODERS radiomic predictive model performs well on an independent dataset and may facilitate the management of indeterminate pulmonary nodules.

摘要

引言

低剂量胸部计算机断层扫描(CT)肺癌筛查的实施以及横断面成像的使用日益增加,导致发现了许多筛查和偶然发现的不确定肺结节。虽然对恶性肿瘤预测试概率低或高的结节的管理相对简单,但那些预测试概率中等的结节通常需要先进的成像或活检。非常需要非侵入性风险分层工具。

方法

我们之前开发了BRODERS分类器(使用放射组学分层的良性侵袭性结节评估),这是一种基于八个成像特征的传统预测放射组学模型,这些特征捕获结节的位置、形状、大小、纹理和表面特征。在此,我们报告了其与Brock模型相比,使用偶然发现的肺结节数据集(范德比尔特大学肺结节登记处)进行的外部验证。计算曲线下面积(AUC)以及敏感性、特异性、阴性和阳性预测值。

结果

对于整个范德比尔特验证集(n = 170,54%为恶性),Brock模型的AUC为0.87(95%CI 0.81 - 0.92),BRODERS模型的AUC为0.90(95%CI 0.85 - 0.94)。使用约登指数确定的最佳截断值,敏感性为92.3%,特异性为62.0%,阳性(PPV)和阴性预测值(NPV)分别为73.7%和87.5%。对于恶性肿瘤预测试概率中等的结节,Brock评分为5 - 65%(n = 97),敏感性和特异性分别为94%和46%,PPV为78.4%,NPV为79.2%。

结论

BRODERS放射组学预测模型在独立数据集上表现良好,可能有助于不确定肺结节的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412a/8375083/c6333c66452f/nihms-1730917-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412a/8375083/9d4fc5997c08/nihms-1730917-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412a/8375083/c6333c66452f/nihms-1730917-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412a/8375083/9d4fc5997c08/nihms-1730917-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412a/8375083/c6333c66452f/nihms-1730917-f0002.jpg

相似文献

1
Validation of the BRODERS classifier (Benign aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.BRODERS分类器(使用放射组学分层进行良性侵袭性结节评估)的验证,这是一种基于高分辨率CT的新型放射组学分类器,用于评估不确定的肺结节。
Eur Respir J. 2021 Apr 1;57(4). doi: 10.1183/13993003.02485-2020. Print 2021 Apr.
2
External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.利用 NLST 数据对 Brock 模型进行外部验证和重新校准,以预测肺结节中癌症的概率。
Thorax. 2019 Jun;74(6):551-563. doi: 10.1136/thoraxjnl-2018-212413. Epub 2019 Mar 21.
3
Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.基于新型高分辨率 CT 的放射组学分类器,用于国家肺癌筛查试验中经筛查发现的肺结节。
PLoS One. 2018 May 14;13(5):e0196910. doi: 10.1371/journal.pone.0196910. eCollection 2018.
4
Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches.基于机器学习的影像组学分析预测肺结节良恶性。
Thorax. 2024 Mar 15;79(4):307-315. doi: 10.1136/thorax-2023-220226.
5
The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.偶然发现肺部结节的患者肺癌的概率:临床特征和预测模型的准确性。
Chest. 2022 Feb;161(2):562-571. doi: 10.1016/j.chest.2021.07.2168. Epub 2021 Aug 6.
6
Prediction efficacy of feature classification of solitary pulmonary nodules based on CT radiomics.基于 CT 影像组学的孤立性肺结节特征分类预测效能。
Eur J Radiol. 2021 Jun;139:109667. doi: 10.1016/j.ejrad.2021.109667. Epub 2021 Mar 18.
7
A Low-Dose CT-Based Radiomic Model to Improve Characterization and Screening Recall Intervals of Indeterminate Prevalent Pulmonary Nodules.一种基于低剂量CT的放射组学模型,用于改善对不确定的肺部实性结节的特征描述及筛查召回间隔时间
Diagnostics (Basel). 2021 Sep 3;11(9):1610. doi: 10.3390/diagnostics11091610.
8
Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.联合血清微小RNA、癌胚抗原和细胞角蛋白19片段与影像学及临床特征鉴别肺结节的良恶性:一项初步研究:李先锋等人:联合生物标志物、影像学和临床特征鉴别肺结节
World J Surg Oncol. 2017 May 25;15(1):107. doi: 10.1186/s12957-017-1171-y.
9
Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.循环遗传异常细胞对支持 CT 诊断良、恶性肺结节的价值。
BMC Cancer. 2022 Apr 9;22(1):382. doi: 10.1186/s12885-022-09472-w.
10
Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.肺癌筛查中基于放射组学列线图的恶性肺结节术前诊断。
Cancer Commun (Lond). 2020 Jan;40(1):16-24. doi: 10.1002/cac2.12002. Epub 2020 Mar 3.

引用本文的文献

1
From images to clinical insights: an educational review on radiomics in lung diseases.从图像到临床见解:关于肺部疾病放射组学的教育性综述
Breathe (Sheff). 2025 Mar 18;21(1):230225. doi: 10.1183/20734735.0225-2023. eCollection 2025 Jan.
2
A predictive clinical-radiomics nomogram for early diagnosis of mesenteric arterial embolism based on non-contrast CT and biomarkers.基于非增强CT和生物标志物的肠系膜动脉栓塞早期诊断预测性临床影像组学列线图
Abdom Radiol (NY). 2025 Jan 15. doi: 10.1007/s00261-024-04745-3.
3
Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG).

本文引用的文献

1
Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules.评估深度学习方法对不确定肺结节进行风险分层的准确性。
Am J Respir Crit Care Med. 2020 Jul 15;202(2):241-249. doi: 10.1164/rccm.201903-0505OC.
2
Lung Cancer 2020: Epidemiology, Etiology, and Prevention.肺癌 2020:流行病学、病因学和预防。
Clin Chest Med. 2020 Mar;41(1):1-24. doi: 10.1016/j.ccm.2019.10.001.
3
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.随机试验中 CT 容积筛查降低肺癌死亡率
肺癌筛查及筛查后肺结节管理综合系统的开发与验证:一项概念验证研究(ASCEND-LUNG)
EClinicalMedicine. 2024 Aug 3;75:102769. doi: 10.1016/j.eclinm.2024.102769. eCollection 2024 Sep.
4
Deep learning in pulmonary nodule detection and segmentation: a systematic review.深度学习在肺结节检测与分割中的应用:一项系统综述。
Eur Radiol. 2025 Jan;35(1):255-266. doi: 10.1007/s00330-024-10907-0. Epub 2024 Jul 10.
5
Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?用于肺结节风险分层的放射组学和人工智能:准备好进入黄金时段了吗?
Cancer Biomark. 2024 Feb 6:CBM230360. doi: 10.3233/CBM-230360.
6
Assessment of interobserver concordance in radiomic tools for lung nodule classification, with a focus on BRODERS and SILA.评估肺结节分类的放射组学工具的观察者间一致性,重点关注 BRODERS 和 SILA。
Sci Rep. 2023 Dec 8;13(1):21725. doi: 10.1038/s41598-023-48567-7.
7
Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules.肺结节良恶性评估的生物标志物研究进展。
Chest. 2023 Oct;164(4):1028-1041. doi: 10.1016/j.chest.2023.05.025. Epub 2023 May 25.
8
Improving Lung Cancer Diagnosis with CT Radiomics and Serum Histoplasmosis Testing.CT 放射组学和血清组织胞浆菌检测提高肺癌诊断水平。
Cancer Epidemiol Biomarkers Prev. 2023 Mar 6;32(3):329-336. doi: 10.1158/1055-9965.EPI-22-0532.
9
The Intervention Probability Curve: Modeling the Practical Application of Threshold-Guided Decision-Making, Evaluated in Lung, Prostate, and Ovarian Cancers.干预概率曲线:对阈值引导决策的实际应用进行建模,在肺癌、前列腺癌和卵巢癌中进行评估。
Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1752-1759. doi: 10.1158/1055-9965.EPI-22-0190.
10
The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.肺 EDRN-CVC 对 1 期、2 期和 3 期生物标志物验证研究的影响。
Cancer Biomark. 2022;33(4):449-465. doi: 10.3233/CBM-210382.
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
4
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
5
Reproduction study using public data of: Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs.使用公共数据进行生殖研究:开发和验证一种用于眼底照片中糖尿病性视网膜病变检测的深度学习算法。
PLoS One. 2019 Jun 6;14(6):e0217541. doi: 10.1371/journal.pone.0217541. eCollection 2019.
6
End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography.基于低剂量 CT 的三维深度学习肺癌全流程筛查。
Nat Med. 2019 Jun;25(6):954-961. doi: 10.1038/s41591-019-0447-x. Epub 2019 May 20.
7
Post-imaging pulmonary nodule mathematical prediction models: are they clinically relevant?影像学后肺结节数学预测模型:它们在临床上有意义吗?
Eur Radiol. 2019 Oct;29(10):5367-5377. doi: 10.1007/s00330-019-06168-x. Epub 2019 Apr 1.
8
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.MILD 试验证实:延长肺癌筛查时间可降低 10 年死亡率,再次确认肺癌筛查的有效性。
Ann Oncol. 2019 Jul 1;30(7):1162-1169. doi: 10.1093/annonc/mdz117.
9
Poor Uptake of Lung Cancer Screening: Opportunities for Improvement.肺癌筛查参与率低:改善机会尚存。
J Am Coll Radiol. 2019 Apr;16(4 Pt A):446-450. doi: 10.1016/j.jacr.2018.12.018. Epub 2019 Feb 15.
10
Deciphering the Molecular Profile of Lung Cancer: New Strategies for the Early Detection and Prognostic Stratification.解析肺癌的分子特征:早期检测与预后分层的新策略
J Clin Med. 2019 Jan 17;8(1):108. doi: 10.3390/jcm8010108.